GRAIL Inc (NAS:GRAL)
$ 75.53 -0.70 (-0.92%) Market Cap: 3.37 Bil Enterprise Value: 2.60 Bil PE Ratio: 0 PB Ratio: 1.33 GF Score: 11/100

Grail Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 14, 2026 / 03:30PM GMT
Release Date Price: $75.53 (-0.92%)
Kallum Titchmarsh
Morgan Stanley & Co Ltd - Analyst

Perfect. I think we can get started. Kallum Titchmarsh here from the Life Science Tools and Diagnostics team at Morgan Stanley. Thank you all for joining us today, joined by Eric Fung, Chief Medical Officer at GRAIL for a fireside chat discussion. But just before we get started, for all disclosures relating to this presentation, please see morganstanley.com/researchdisclosures.

Questions & Answers

Kallum Titchmarsh
Morgan Stanley & Co Ltd - Analyst

Eric, maybe for those that haven't had the opportunity to meet you, could you just tell us a little bit more about yourself and your kind of involvement with GRAIL during those 9 years I think you've been in there.

Eric Fung
Grail Inc - Senior Vice President, Chief Medical Officer

Yes. Well, thank you, Kallum, and thanks for the Morgan Stanley team for having us here. I'm Eric Fung, Chief Scientific Officer for GRAIL. I've been at GRAIL as concept for 9 years. I really spent my life -- my career

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot